BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 33434066)

  • 1. Determinants of COVID-19 Mortality in Patients With Cancer From a Community Oncology Practice in Brazil.
    Ferrari BL; Ferreira CG; Menezes M; De Marchi P; Canedo J; Melo AC; Jácome AA; Reinert T; Paes RD; Sodré B; Barrios CH; Dienstmann R
    JCO Glob Oncol; 2021 Jan; 7():46-55. PubMed ID: 33434066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mortality and critical care unit admission associated with the SARS-CoV-2 lineage B.1.1.7 in England: an observational cohort study.
    Patone M; Thomas K; Hatch R; Tan PS; Coupland C; Liao W; Mouncey P; Harrison D; Rowan K; Horby P; Watkinson P; Hippisley-Cox J
    Lancet Infect Dis; 2021 Nov; 21(11):1518-1528. PubMed ID: 34171232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 infection and mortality during the first epidemic wave in Madurai, south India: a prospective, active surveillance study.
    Laxminarayan R; B CM; G VT; Arjun Kumar KV; Wahl B; Lewnard JA
    Lancet Infect Dis; 2021 Dec; 21(12):1665-1676. PubMed ID: 34399090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study.
    Garassino MC; Whisenant JG; Huang LC; Trama A; Torri V; Agustoni F; Baena J; Banna G; Berardi R; Bettini AC; Bria E; Brighenti M; Cadranel J; De Toma A; Chini C; Cortellini A; Felip E; Finocchiaro G; Garrido P; Genova C; Giusti R; Gregorc V; Grossi F; Grosso F; Intagliata S; La Verde N; Liu SV; Mazieres J; Mercadante E; Michielin O; Minuti G; Moro-Sibilot D; Pasello G; Passaro A; Scotti V; Solli P; Stroppa E; Tiseo M; Viscardi G; Voltolini L; Wu YL; Zai S; Pancaldi V; Dingemans AM; Van Meerbeeck J; Barlesi F; Wakelee H; Peters S; Horn L;
    Lancet Oncol; 2020 Jul; 21(7):914-922. PubMed ID: 32539942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of hospital-acquired SARS-CoV-2 infection in the Canadian first wave epicentre: a retrospective cohort study.
    Melançon E; Brosseau M; Bartoli A; Labbé AC; Lavallée C; Marchand-Senécal X; Wang HT
    CMAJ Open; 2022; 10(1):E74-E81. PubMed ID: 35105684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of hospitalisation associated with infection with SARS-CoV-2 lineage B.1.1.7 in Denmark: an observational cohort study.
    Bager P; Wohlfahrt J; Fonager J; Rasmussen M; Albertsen M; Michaelsen TY; Møller CH; Ethelberg S; Legarth R; Button MSF; Gubbels S; Voldstedlund M; Mølbak K; Skov RL; Fomsgaard A; Krause TG;
    Lancet Infect Dis; 2021 Nov; 21(11):1507-1517. PubMed ID: 34171231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer and COVID-19: analysis of patient outcomes.
    Aboueshia M; Hussein MH; Attia AS; Swinford A; Miller P; Omar M; Toraih EA; Saba N; Safah H; Duchesne J; Kandil E
    Future Oncol; 2021 Sep; 17(26):3499-3510. PubMed ID: 34263660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study.
    Kuderer NM; Choueiri TK; Shah DP; Shyr Y; Rubinstein SM; Rivera DR; Shete S; Hsu CY; Desai A; de Lima Lopes G; Grivas P; Painter CA; Peters S; Thompson MA; Bakouny Z; Batist G; Bekaii-Saab T; Bilen MA; Bouganim N; Larroya MB; Castellano D; Del Prete SA; Doroshow DB; Egan PC; Elkrief A; Farmakiotis D; Flora D; Galsky MD; Glover MJ; Griffiths EA; Gulati AP; Gupta S; Hafez N; Halfdanarson TR; Hawley JE; Hsu E; Kasi A; Khaki AR; Lemmon CA; Lewis C; Logan B; Masters T; McKay RR; Mesa RA; Morgans AK; Mulcahy MF; Panagiotou OA; Peddi P; Pennell NA; Reynolds K; Rosen LR; Rosovsky R; Salazar M; Schmidt A; Shah SA; Shaya JA; Steinharter J; Stockerl-Goldstein KE; Subbiah S; Vinh DC; Wehbe FH; Weissmann LB; Wu JT; Wulff-Burchfield E; Xie Z; Yeh A; Yu PP; Zhou AY; Zubiri L; Mishra S; Lyman GH; Rini BI; Warner JL;
    Lancet; 2020 Jun; 395(10241):1907-1918. PubMed ID: 32473681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Filling the gaps in the characterization of the clinical management of COVID-19: 30-day hospital admission and fatality rates in a cohort of 118 150 cases diagnosed in outpatient settings in Spain.
    Prieto-Alhambra D; Balló E; Coma E; Mora N; Aragón M; Prats-Uribe A; Fina F; Benítez M; Guiriguet C; Fàbregas M; Medina-Peralta M; Duarte-Salles T
    Int J Epidemiol; 2021 Jan; 49(6):1930-1939. PubMed ID: 33118037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mobility as a driver of severe acute respiratory syndrome coronavirus 2 in cancer patients during the second coronavirus disease 2019 pandemic wave.
    Fong D; Mair MJ; Lanthaler F; Alber M; Mitterer M
    Int J Cancer; 2022 Feb; 150(3):431-439. PubMed ID: 34610144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19).
    Lièvre A; Turpin A; Ray-Coquard I; Le Malicot K; Thariat J; Ahle G; Neuzillet C; Paoletti X; Bouché O; Aldabbagh K; Michel P; Debieuvre D; Canellas A; Wislez M; Laurent L; Mabro M; Colle R; Hardy-Bessard AC; Mansi L; Colomba E; Bourhis J; Gorphe P; Pointreau Y; Idbaih A; Ursu R; Di Stefano AL; Zalcman G; Aparicio T;
    Eur J Cancer; 2020 Dec; 141():62-81. PubMed ID: 33129039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High mortality rate in cancer patients with symptoms of COVID-19 with or without detectable SARS-COV-2 on RT-PCR.
    Assaad S; Avrillon V; Fournier ML; Mastroianni B; Russias B; Swalduz A; Cassier P; Eberst L; Steineur MP; Kazes M; Perol M; Michallet AS; Rey P; Erena-Penet AS; Morel A; Brahmi M; Dufresne A; Tredan O; Chvetzoff G; Fayette J; de la Fouchardiere C; Ray-Coquard I; Bachelot T; Saintigny P; Tabutin M; Dupré A; Nicolas-Virelizier E; Belhabri A; Roux PE; Fuhrmann C; Pilleul F; Basle A; Bouhamama A; Galvez C; Herr AL; Gautier J; Chabaud S; Zrounba P; Perol D; Blay JY
    Eur J Cancer; 2020 Aug; 135():251-259. PubMed ID: 32540204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical presentation and course of the novel coronavirus disease 2019 in patients with various types of cancer: A retrospective case-control analysis of an experienced cancer center in Turkey.
    Acar R; Yilmaz G; Savasci U; Aykan MB; Kiziloz H; Cuce F; Kadioglu E; Filiz M; Fidan G; Eksert S; Taskin G; Dogan D; Arslan Y; Tasci C; Kayahan N; Dogan T; Basgoz BB; Sertoglu E; Erturk I; Keskin GSY; Okcelik S; Yildiz B; Karadurmus N
    J Cancer Res Ther; 2021; 17(2):556-564. PubMed ID: 34121708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No detection of SARS-CoV-2 from urine, expressed prostatic secretions, and semen in 74 recovered COVID-19 male patients: A perspective and urogenital evaluation.
    Ruan Y; Hu B; Liu Z; Liu K; Jiang H; Li H; Li R; Luan Y; Liu X; Yu G; Xu S; Yuan X; Wang S; Yang W; Ye Z; Liu J; Wang T
    Andrology; 2021 Jan; 9(1):99-106. PubMed ID: 33150723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct Outcomes in COVID-19 Patients with Positive or Negative RT-PCR Test.
    Saad Menezes MC; Santinelli Pestana DV; Ferreira JC; Ribeiro de Carvalho CR; Felix MC; Marcilio IO; da Silva KR; Junior VC; Marchini JF; Alencar JC; Gomez LMG; Mauá DD; Souza HP; Emergency Usp Covid-Group ; Hcfmusp Covid-Study Group
    Viruses; 2022 Jan; 14(2):. PubMed ID: 35215772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Covid-19 deaths in Africa: prospective systematic postmortem surveillance study.
    Mwananyanda L; Gill CJ; MacLeod W; Kwenda G; Pieciak R; Mupila Z; Lapidot R; Mupeta F; Forman L; Ziko L; Etter L; Thea D
    BMJ; 2021 Feb; 372():n334. PubMed ID: 33597166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 nosocomial infection: Real-world results of environmental surface testing from a large tertiary cancer center.
    Shah MR; Jan I; Johns J; Singh K; Kumar P; Belarmino N; Saggiomo KJ; Hayes C; Washington K; Toppmeyer DL; Haffty BG; Libutti SK; Evens AM
    Cancer; 2021 Jun; 127(11):1926-1932. PubMed ID: 33599303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of smoking on COVID-19-related mortality: a Brazilian national cohort study.
    Oliveira FES; Oliveira MCL; Martelli DRB; Trezena S; Sampaio CA; Colosimo EA; A Oliveira E; Martelli Júnior H
    Addict Behav; 2024 Sep; 156():108070. PubMed ID: 38796931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection.
    Dinnes J; Deeks JJ; Berhane S; Taylor M; Adriano A; Davenport C; Dittrich S; Emperador D; Takwoingi Y; Cunningham J; Beese S; Domen J; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Taylor-Phillips S; Hooft L; Leeflang MM; McInnes MD; Spijker R; Van den Bruel A;
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013705. PubMed ID: 33760236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.